HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma.

Abstract
Karyopherins mediate the macromolecular transport between the cytoplasm and the nucleus and participate in cancer progression. However, the role and mechanism of importin-11 (IPO11), a member of the karyopherin family, in glioma progression remain undefined. Effects of IPO11 on glioma progression were detected using CCK-8, colony formation assay, flow cytometry analysis, caspase-3 activity assay, and Transwell invasion assay. Western blot analysis was used to detect the expression of active caspase-3, active caspase-7, active caspase-9, N-cadherin, Vimentin, E-cadherin, β-catenin, and c-Myc. The activity of Wnt/β-catenin pathway was evaluated by the T-cell factor/lymphoid enhancer factor (TCF/LEF) transcription factor reporter assay. Results showed that IPO11 knockdown inhibited proliferation and reduced colony number in glioma cells. IPO11 silencing promoted the apoptotic rate, increased expression levels of active caspase-3, caspase-7, and caspase-9, and enhanced caspase-3 activity. Moreover, IPO11 silencing inhibited glioma cell invasion by suppressing epithelial-to-mesenchymal transition (EMT). Mechanistically, IPO11 knockdown inactivated the Wnt/β-catenin pathway. β-Catenin overexpression abolished the effects of IPO11 silencing on the proliferation, apoptosis, and invasion in glioma cells. Furthermore, IPO11 silencing blocked the malignant phenotypes and repressed the Wnt/β-catenin pathway in vivo. In conclusion, IPO11 knockdown suppressed the malignant phenotypes of glioma cells by inactivating the Wnt/β-catenin pathway.
AuthorsHongzao Ni, Daofei Ji, Jing Li, Zongren Zhao, Jiandong Zuo
JournalInternational journal of biological macromolecules (Int J Biol Macromol) Vol. 176 Pg. 145-156 (Apr 15 2021) ISSN: 1879-0003 [Electronic] Netherlands
PMID33571591 (Publication Type: Journal Article)
CopyrightCopyright © 2021. Published by Elsevier B.V.
Chemical References
  • CTNNB1 protein, human
  • Carcinogens
  • IPO11 protein, human
  • beta Catenin
  • beta Karyopherins
Topics
  • Animals
  • Apoptosis (genetics, physiology)
  • Brain Neoplasms (genetics, metabolism, pathology)
  • Carcinogens (antagonists & inhibitors, metabolism)
  • Cell Line, Tumor
  • Cell Proliferation (genetics, physiology)
  • Female
  • Gene Knockdown Techniques
  • Glioma (genetics, metabolism, pathology)
  • Heterografts
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Invasiveness (genetics, pathology, physiopathology)
  • Phenotype
  • Transcriptome
  • Up-Regulation
  • Wnt Signaling Pathway
  • beta Catenin (genetics, metabolism)
  • beta Karyopherins (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: